Promising New Treatment for Patients with HR+ HER-2 Negative Metastatic Breast Cancer
New research from Yale Cancer Center reveals first-of-its-kind data from a phase I study in patients with hormone receptor positive HER2-negative metastatic breast cancer. The results, which assess the safety and efficacy of a treatment known as...
30-May-2024 3:05 PM EDT
Add to Favorites